Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
8.00    0.875 (12.28%)
Bid:
7.50
Ask:
8.50
Spread: 1.00 (13.333%)
Market Cap: £9.56m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Director Dealing

Today 13:30

Marechale Capital Plc - Director Dealing

Marechale Capital Plc - Director Dealing

PR Newswire

LONDON, United Kingdom, June 23

23 June 2026

Marechale Capital plc

(“Marechale” or the "Company")

Director Dealing

Marechale Capital plc, an established London based corporate finance advisory business, announces that on 23 June 2026 it was informed that on 23 June 2026, Mr. Chris Kenning, Non-executive Director of the Company had transferred a part of his shareholding, representing 9,146,670 ordinary shares in the Company, to 1Edge Insurance PCC Limited ("1Edge"), a private company indirectly controlled by Mr. Kenning (the “Transfer”).

Further, to settle a personal tax liability with respect to the Transfer, on 22 June 2026 Mr. Kenning sold 3,000,000 ordinary shares in the Company.

Mr. Kenning remains fully committed to the Company's strategic growth and continues in his role as a Non-executive Director.

Details of the Transfer and the sale of ordinary shares are set out in the Notification of Dealing Form below.

Director/PCA Interest prior to Transfer and sale Number of ordinary shares transferred Number of ordinary shares sold Resultant direct interest in ordinary shares in the Company Resultant direct percentage of voting rights in the Company
Chris Kenning 12,146,670 9, 146,670 3,000,000 - -
1Edge* - - - 9, 146,670 3.56%
*1Edge Insurance PCC Limited is 100 per cent. owned by Stubben Edge Group Limited, whose largest shareholder and regulated controller is Mr. Kenning

Following the above Transfer and sale, the aggregate interest of Mr. Kenning, including the ordinary shares held by 1Edge, is 9,146,670 ordinary shares in the Company, representing approximately 3.56 per cent. of the Company’s enlarged issued share capital, as noted in the announcement 22 June 2026.

Mr. Kenning also has an interest in 250,000 options over ordinary shares in the Company.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

The Directors of the Company take responsibility for this announcement.

Enquiries

Marechale Capital

Patrick Booth-Clibborn / Mark Warde-Norbury

Tel: +44 (0)20 7628 5582

Cairn Financial Advisers LLP

(Nominated Adviser)

Jo Turner / Sandy Jamieson

Tel: +44 (0)20 7213 0880

Vigo Consulting

(Financial Public Relations)

Jeremy Garcia / Joe Quinlan

marechale@vigoconsulting.com

Tel: +44 (0)20 7390 0230

Forward looking statement disclaimer

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.

The Company cautions shareholders and prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person closely associated
a. Name Chris Kenning 1Edge Insurance PCC Limited (“1Edge”)
2 Reason for notification
a. Position/Status Non-executive Director PCA of Chris Kenning, Non-executive Director
b. Initial notification/ Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name Marechale Capital plc
b. LEI 2138003NUK6SXCDIAT89
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the financial instrument, type of instrumentIdentification Code Ordinary Shares ISIN: GB0005401087
b. Nature of the transaction Transfer / receipt of ordinary shares Sale of ordinary shares
c. Price(s) and volume(s): Price(s) per share (p) Volume(s)

Chris Kenning

1) N/A

2) 8.3p

1Edge

1) N/A

Chris Kenning

1) 9,146,670 (Transfer of shares)

2) 3,000,000

1Edge

1) 9,146,670 (Receipt of shares)

d. Aggregated information Volume Price Volume Price Transfer / receipt of shares

9,146,670

N/A

Sale of shares

3,000,000

8.3p

e. Date of the transaction 23/06/2026 22/06/2026
f. Place of the transaction Outside a trading venue AIM


Date   Source Headline
21st Dec 20117:00 amRNSHalf Yearly Report
11th Nov 20113:58 pmRNSChange of Registered Office
9th Nov 20112:50 pmRNSHolding(s) in Company
22nd Sep 201111:20 amRNSResult of AGM
20th Sep 201110:03 amRNSDirector/PDMR Shareholding
25th Aug 20119:46 amRNSFinal Results
18th Apr 20111:44 pmRNSDirector/PDMR Shareholding
14th Apr 20112:16 pmRNSHolding(s) in Company
12th Apr 20117:00 amRNSDirectorate Change
31st Mar 20113:28 pmRNSIssue of Equity
29th Mar 20113:17 pmRNSDirectorate Appointment & Dealing
28th Mar 20113:39 pmRNSDirector/PDMR Shareholding
16th Mar 20119:20 amRNSDirector/PDMR Shareholding
25th Feb 20113:46 pmRNSHolding(s) in Company
9th Feb 20112:02 pmRNSDirector/PDMR Shareholding
19th Jan 20111:34 pmRNSDirector/PDMR Shareholding
13th Jan 20114:19 pmRNSHolding(s) in Company
11th Jan 201112:27 pmRNSDirector/PDMR Shareholding
15th Dec 201012:00 pmRNSHalf Yearly Report
29th Sep 20103:06 pmRNSResult of AGM
22nd Sep 201010:34 amRNSDirector/PDMR Shareholding
7th Sep 201012:00 pmRNSFinal Results and Notice of General Meeting
17th Mar 20109:00 amRNSChange of Adviser
22nd Feb 20103:15 pmRNSResult of GM
12th Feb 201012:00 pmRNSDirector/PDMR Shareholding
4th Feb 201011:00 amRNSDirector/PDMR Shareholding
29th Jan 201012:00 pmRNSNotice of General Meeting
12th Jan 20107:00 amRNSApplication for New Ordinary Shares
23rd Dec 20092:31 pmRNSHalf Yearly Report
17th Dec 20095:15 pmRNSResult of AGM
7th Dec 200912:28 pmRNSHoldings in Company / Directors Dealings
23rd Nov 20097:00 amRNSAcquisition and AGM
23rd Oct 20099:17 amRNSHolding in Company
15th Oct 20092:41 pmRNSChange of Name of Nominated Adviser and Broker
30th Sep 20094:00 pmRNSAnnual Report & Accounts
18th Sep 20097:00 amRNSNotifiable Interests
18th Sep 20097:00 amRNSHolding in Company
28th Aug 20092:30 pmRNSAcquisition of Whim Gully Capital LLP
28th Aug 20092:30 pmRNSPreliminary Results and Notice of General Meeting
21st Jul 20097:00 amRNSDisposal
6th Aug 200810:59 amRNSDirector/PDMR Shareholding
23rd Jun 20087:00 amRNSAppointment of joint broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.